by Joe Rojas-Burke, Oregon Health & Science University Graphical abstract. Credit: Cancer Cell (2022). DOI: 10.1016/j.ccell.2022.07.002 Acute myeloid leukemia, or AML, is the most common acute blood cancer in adults—and one of the most difficult to treat. Scientists at Oregon Health & Science University have discovered a potential new target for stopping it: a gene that, when active,...
